Status:
COMPLETED
Misoprostol Versus Oxytocin for Prevention of Post Partum Hemorrhage
Lead Sponsor:
Hormozgan University of Medical Sciences
Conditions:
Post Partum Hemorrhage
Eligibility:
FEMALE
10-50 years
Phase:
PHASE1
Brief Summary
Post partum Hemorrhage (PPH) is one of three main causes of death in pregnant women. Oxytocin is widely used for prevention of PPH. Some studies suggested misoprostol as an alternative treatment when ...
Detailed Description
In a double blind randomized controlled trial 400 pregnant women who has vaginal delivery at Shariati hospital are assigned into two groups either to receive 20 unite oxytocin in 1000cc ringer and 2 p...
Eligibility Criteria
Inclusion
- were women with singleton pregnancy
- with cephalic presentation
- who had NVD spontaneously or by induction
Exclusion
- placenta previa
- placental detachment
- coagulation problems
- previous CS
- macrosomia
- Polyhydramnios
- and uncontrolled asthma
Key Trial Info
Start Date :
May 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2013
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT01863706
Start Date
May 1 2013
End Date
December 1 2013
Last Update
March 26 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hormozgan University of Medical Sciences
Bandar Abbas, Hormozgan, Iran, 097145-3388